Crossmark Global Holdings’s Medifast MED Stock Holding History
Bought
Maintained
Sold
Other funds holding MED
RHJA
PAMS
Crossmark Global Holdings's MED Position: Q1 2022 in Review
Crossmark Global Holdings sold out of Medifast (MED) in Q1 2022, closing a stake of 1,100 shares — an estimated $230K sold.
Crossmark Global Holdings first reported a position in MED in Q4 2017 and held it in 16 quarters. The position peaked at $1.21M in Q2 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.
- Crossmark Global Holdings reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
- Crossmark Global Holdings sold 1,100 Medifast shares in Q1 2022, an estimated $230K.
- Crossmark Global Holdings first reported a position in Medifast in Q4 2017 and held it in 16 quarters.
- Crossmark Global Holdings's Medifast position peaked at $1.21M in Q2 2021.
- 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.
Based on Crossmark Global Holdings's 13F filing for Q1 2022, filed 11 May 2022.